← FDA DRUG APPROVALS

FDA NDA · NDA018040

MONISTAT

Sponsor: JANSSEN PHARMA

APPLICATION
NDA018040
TYPE
NDA
ORIGINAL APPROVAL
1978-10-04
LATEST ACTION
1997-06-25
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

MONISTATDiscontinued
MICONAZOLE 10MG/ML · INJECTABLE · INJECTION

Approval history

1997-06-25Labeling · Supplement 4AP
1993-07-08Labeling · Supplement 13AP
1990-03-09Labeling · Supplement 9AP
1982-04-20Labeling · Supplement 5AP
1979-03-08Labeling · Supplement 2AP
1978-11-20Labeling · Supplement 1AP
1978-10-04Type 3 - New Dosage Form · Original · priorityAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →